Program Detail
Modality
Program #
Program
indication
Presentation
Source
Respiratory syncytial virus (RSV) vaccine
Last program update Nov 06, 2019
Source
Human metapneumovirus and \nparainfluenza virus 3 (hMPV+PIV3) vaccine
Last program update Nov 06, 2019
Source
Personalized Cancer Vaccine (PCV) \n\iSolid tumors/i
Last program update Nov 06, 2019
Source
KRAS vaccine \n\iCRC, NSCLC, pancreatic cancer/i
Last program update Nov 06, 2019
Source
OX40L \n\iSolid tumors/lymphoma/i\n\iAdvanced ovarian carcinoma/i
Last program update Nov 06, 2019
Source
OX40L+IL23+IL36γ \n\iSolid tumors/lymphoma/i
Last program update Nov 06, 2019